ERBB2 and neoplasm: However, HCT-mono-mIL12 needs to strongly bind to HER2 at a certain threshold level to achieve durable tumor retention (Figure 6, step 1); otherwise, it will be systemically eliminated through rapid diffusion out of the tumor.